COLLEGIUM PHARMACEUTICAL, INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $780.6 | $631.4 | $566.8 | $463.9 | $276.9 |
| Operating income | $179.6 | $169.9 | $167.0 | $33.3 | $17.6 |
| Net income | $62.9 | $69.2 | $48.2 | -$25.0 | $71.5 |
| Cash Flow Statement | |||||
| Free cash flow | $327.6 | $203.3 | $274.3 | $122.6 | $101.6 |
| Share repurchases | $25.1 | $60.0 | $75.0 | $14.1 | $47.9 |
Shares outstanding 32.6M · Free float 72.3%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.